Breast Cancer News

Those with more muscle had higher survival rates, regardless of their age or cancer stage, ABC News reported.

Genetic testing is already a billion-dollar industry, and some research estimates that it could grow to $10 billion in the next decade.

The disease -- breast implant-associated anaplastic large-cell lymphoma -- is not breast cancer. It's an immune system cancer that can usually be cured by surgery alone if detected early, The Times reported.

The average size of breast tumors at diagnosis fell 23 percent during that time -- from 26 millimeters to 20 millimeters (1.02 to 0.79 inches), the researchers found.

The study included just over 1,700 women with early stage breast cancer who could benefit from genetic testing.

U.S. Preventive Services Task Force guidelines recommend beginning breast cancer screening at age 50 for women at average risk. But it hasn't been clear if a single guideline can be applied to different racial or ethnic groups, the researchers noted.

The test, from 23andMe,  analyzes DNA from saliva collected by clients, the FDA said in an agency news release.

The study of more than 300 women who underwent breast radiation found that almost half had heard "frightening" stories going into treatment. But only 2 percent ultimately agreed that the stories were true.

In a study in Germany, the new technique reduced false-positive findings by 70 percent. The scan was also able to detect 98 percent of breast cancers correctly, the researchers said.

It's well-known that treatments such as chest radiation and certain drugs can damage the heart, sometimes leading to chronic heart disease.

After the rule went into effect, the study found, the number of women in Medicare Advantage plans who got mammography screening rose by 5.5 percentage points: from just under 60 percent in the two years before the rule, to 65.4 percent in the two years after.

BRCA mutations are inherited and increase the risk of breast and ovarian cancers. Between 45 percent and 90 percent of women with a BRCA mutation develop breast cancer, compared with about 12.5 percent of women in the general population.

These women are also more likely to put off seeing a doctor if they do find a suspicious lump in their breast, the study found.

Fewer women with early stage breast cancer are turning to chemotherapy to fight their disease, a new study finds.

It's never too late for women to lose weight to lower their breast cancer risk, a new study suggests.

Women with earlier-stage breast cancer may be able to spend less time on hormonal therapy without dimming their prognosis, a new study suggests.

The finding could be a win-win for breast cancer patients,  said one oncologist who reviewed the study.

Still, experts cautioned that the absolute risk of breast cancer for any one woman on the Pill remains very low.

Adding a new drug to standard treatment can slow the progression of advanced breast cancer in younger women, a new clinical trial has found.

Highlights from the 2017 San Antonio Breast Cancer Symposium.

Currently, the U.S. Preventive Services Task Force recommends that women at average risk for breast cancer be screened every two years, beginning at age 50.

Overweight or obese women are at greater risk of having breast cancer detected after the tumor has grown large -- over 2 centimeters -- than their slimmer counterparts, the study found.

Type 2 diabetes may increase the risk for an aggressive type of breast cancer among black women in the United States, a new study finds.

Women treated for early stage breast cancer still face a substantial risk of recurrence up to 20 years later, a large, new study shows.

Many breast cancer patients skip recommended treatment after surgery because they lack faith in the health care system, a new study indicates.